1. A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults. (2nd July 2020) Authors: Wang, Jiaxue; Niu, Suping; Dong, Wenliang; Wei, Li; Ou, Lun; Zhang, Tan; Zhang, Liangbi; Nie, Xiaoyan; Wang, Qian; Shen, Tiantian; Wang, Qi; Xia, Lin; Liu, Gang; Jin, Jiting; Zheng, Qingshan; Song, Haifeng; Fang, Yi Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 7(2020) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative efficacy and safety of 8 GLP-1RAs in patients with type 2 diabetes: A network meta-analysis. (July 2021) Authors: Xia, Lin; Shen, Tiantian; Dong, Wenliang; Su, Feng; Wang, Jiaxue; Wang, Qian; Niu, Suping; Fang, Yi Journal: Diabetes research and clinical practice Issue: Volume 177(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neutrophil peptide-1 promotes the repair of sciatic nerve injury through the expression of proteins related to nerve regeneration. (4th March 2022) Authors: Yu, Fei; Yuan, Yusong; Xu, Hailin; Niu, Suping; Han, Na; Zhang, Yajun; Yin, Xiaofeng; Kou, Yuhui; Jiang, Baoguo Journal: Nutritional neuroscience Issue: Volume 25:Number 3(2022) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial. (1st February 2022) Authors: Dong, Wenliang; Chen, Min; Niu, Suping; Wang, Bianzhen; Xia, Lin; Wang, Jiaxue; Shen, Tiantian; Wang, Qian; Lv, Jie; Liu, Gang; Fan, Huaying; Xie, Zhenwei; Xie, Fan; an, Youzhong; Zheng, Qingshan; Rao, Huiying; Song, Haifeng; Fang, Yi Journal: Expert opinion on biological therapy Issue: Volume 22:Number 2(2022) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose–escalation study. (1st February 2023) Authors: Yan, Diqin; Niu, Suping; Hu, Dingyuan; Dong, Wenliang; Sun, Yunjuan; Wang, Qian; Wang, Simin; Gu, Qun; Liu, Gang; Wang, Jiaxue; Chen, Liming; Lv, Jie; Zheng, Qingshan; Song, Haifeng; Fang, Yi Journal: Expert opinion on investigational drugs Issue: Volume 32:Number 2(2023) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Predictive value of cardiopulmonary fitness parameters in the prognosis of patients with acute coronary syndrome after percutaneous coronary intervention. Issue 8 (August 2020) Authors: Niu, Suping; Wang, Fei; Yang, Shenghua; Jin, Zongxue; Han, Xuejie; Zou, Shangzhi; Guo, Danjie; Guo, Caixia Journal: Journal of international medical research Issue: Volume 48:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol. Issue 11 (24th November 2020) Authors: Dong, Wenliang; Nie, Xiaoyan; Wang, Jiaxue; Xia, Lin; Cai, Lin; Wang, Qian; Wang, Wei; Fu, Weixing; Wang, Qi; Shen, Tiantian; Fan, Huaying; Niu, Suping; Cui, Yimin; Zheng, Qingshan; Zhang, Jianzhong; Fang, Yi Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol. Issue 11 (24th November 2020) Authors: Dong, Wenliang; Nie, Xiaoyan; Wang, Jiaxue; Xia, Lin; Cai, Lin; Wang, Qian; Wang, Wei; Fu, Weixing; Wang, Qi; Shen, Tiantian; Fan, Huaying; Niu, Suping; Cui, Yimin; Zheng, Qingshan; Zhang, Jianzhong; Fang, Yi Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗